It's hard to bet against this company right now.The group of 1trillionmarketcapstocksistiny,andpharmaceuticalgiantEliLilly(LLY−3.47820 billion.However, the drugmaker's prospects look so strong that not only should it soon join the 1trillionclub,butitcouldevenbeamemberofthemoreexclusive2 trillion club by 2030. Here's why.The tirzepatide tailwindWhat's considered "solid" growth in revenue for a corporation? Th ...